634 related articles for article (PubMed ID: 18064988)
1. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
Abdelli MN; Ben Abdallah H; Houissa F; Bouali MR; Khediri MF
Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
[TBL] [Abstract][Full Text] [Related]
2. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
3. [Factors affecting recurrence after surgical treatment of Crohn disease].
Locatelli L; Scaglione D; Giacobbe U; Lucchesi G; Saracco R; Florentini MT; Ceccopieri B; Bertolino F
Minerva Gastroenterol Dietol; 1995 Jun; 41(2):135-42. PubMed ID: 7647135
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after ileocecal resection for Crohn's disease.
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K; Chen SH
Am Surg; 1997 Jul; 63(7):627-33. PubMed ID: 9202538
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
Myrelid P; Svärm S; Andersson P; Almer S; Bodemar G; Olaison G
Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation.
Murakami Y; Matsui T; Hirai F; Takatsu N; Takaki Y; Nagahama T; Hisabe T; Beppu T; Miyaoka M; Maki S; Takeichi M; Nishimura T; Ueki T; Yao K
Dig Endosc; 2010 Jan; 22(1):25-32. PubMed ID: 20078661
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
Treton X; Bouhnik Y; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Cosnes J; Lemann M;
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
[TBL] [Abstract][Full Text] [Related]
10. [Long term evolution of corticodependant and corticoresistant Crohn's disease patients treated by azzathioprine].
Karoui S; Hamrouni A; Bibani N; Serghini M; Boubaker J; Filali A
Tunis Med; 2011 Jul; 89(7):610-5. PubMed ID: 21780035
[TBL] [Abstract][Full Text] [Related]
11. Clinical and surgical recurrence of Crohn's disease after ileocolonic resection in a specialist unit.
Ng SC; Lied GA; Arebi N; Phillips RK; Kamm MA
Eur J Gastroenterol Hepatol; 2009 May; 21(5):551-7. PubMed ID: 19182680
[TBL] [Abstract][Full Text] [Related]
12. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors of azathioprine prescription in adult patients with Crohn's disease.
Karoui S; Bibani N; Serghini M; Kallel L; Ben Mustapha N; Boubaker J; Filali A
Hepatogastroenterology; 2010; 57(98):283-7. PubMed ID: 20583428
[TBL] [Abstract][Full Text] [Related]
14. [Recurrence of Crohn's disease after surgery--causes and risks].
Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
[TBL] [Abstract][Full Text] [Related]
15. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
16. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas].
Volk-Zeiher BA; Blum HE
Praxis (Bern 1994); 1998 Nov; 87(48):1657-60. PubMed ID: 9881040
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Crohn's disease: risk factors for postoperative recurrence.
Baldassano RN; Han PD; Jeshion WC; Berlin JA; Piccoli DA; Lautenbach E; Mick R; Lichtenstein GR
Am J Gastroenterol; 2001 Jul; 96(7):2169-76. PubMed ID: 11467649
[TBL] [Abstract][Full Text] [Related]
19. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
Christodoulou D; Katsanos K; Baltayannis G; Tzabouras N; Tsianos EV
Hepatogastroenterology; 2003; 50(52):1021-4. PubMed ID: 12845970
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
Markowitz JF
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
